Between 2007 and the end of 2016, 24 countries implemented a total of 25 national tuberculosis prevalence surveys using methods recommended by WHO. The 25 surveys consisted of 13 in Asia and 12 in Africa. Collectively, survey findings have informed the policies, plans and programmatic actions needed to address gaps in TB diagnosis and treatment and to reduce the burden of TB disease. Finally, the 24 countries have a robust baseline for assessing progress towards new global targets set in the UN Sustainable Development Goals (2016–2030) and WHO’s End TB Strategy (2016–2035). The methods, results, successes achieved, challenges faced and lessons learned from the 25 surveys were comprehensively documented in the book. We viewed such a product as a global public good, that should be available to all those with an interest in and commitment to using survey findings, now and in the future e.g. academics, donors, public health officers and national TB programmes. As with implementation of the 25 surveys themselves, the book is the result of a major global, regional and national collaborative and collective effort, with more than 450 contributors from all around the world.

Rev. ed. of: Assessing tuberculosis prevalence through population-based surveys. 2007.

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.

The World Health Organization, through its Global Tuberculosis (TB) Programme, leads and guides the global effort to end the TB epidemic through universal access to people-centred prevention and care, multisectoral action and innovation. Each year, since 1997, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of the progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets. The 2021 edition of the report has been produced in a new and more web-centric format. This is designed to make the content available in smaller (more “bite-sized”) chunks that are easier to read, digest, navigate and use. The short and slim report PDF, with 30 pages of main content and six short annexes, is accompanied by expanded and more detailed digital content on web pages. This document is a compilation of these web pages and should be read in conjunction with the main report.

WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic and of progress in prevention diagnosis and treatment of the disease at global regional and country levels. This is done in the context of recommended global TB strategies and targets endorsed by WHO?s Member States and broader development goals set by the United Nations (UN). The 2018 edition of the global TB report was released on 18 September in the lead up to the first-ever UN High Level Meeting on TB on 26 September 2018.

This report delivers the first systematic analysis of available data to make an authoritative statement on the status of inequality in HIV/AIDS, TB and malaria. Monitoring inequalities in HIV/AIDS, tuberculosis and malaria (in terms of burden, prevention and treatment) helps to pinpoint where there may be gaps and identify population groups that are being left behind, and support countries and international organizations to tailor policies, programmes, and service provision to close these gaps. The objectives of the report are to: assess the latest status and change of inequality in HIV/AIDS, malaria and tuberculosis globally; identify good-performing countries in terms of equity as well as countries that have room for improvement; and investigate the association of inequality with inequality in other health topics, social determinants of health and access to health facilities. This report supports Output 4.1.2 of GPW 13 (GPW 13 impacts and outcomes, global and regional health trends, Sustainable Development Goal indicators, health inequalities and disaggregated data monitored). Similar analysis have been previously conducted and published for other disease topics, including State of inequality: Childhood immunization and State of inequality: Reproductive, maternal, newborn and child health.

WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of recommended global TB strategies and targets endorsed by WHO?s Member States, broader development goals set by the United Nations (UN) and targets set in the political declaration at the first UN high-level meeting on TB (held in September 2018). The 2019 edition of the global TB report was released on 17 October 2019. The data in this report are updated annually. Please note that direct comparisons between estimates of TB disease burden in the latest report and previous reports are not appropriate. The most recent time-series of estimates are published in the 2019 global TB report.

Over the past two decades, there has been a considerable increase in the number of tools to generate, analyse and use data and evidence, to support discussion and decision-making by national TB programmes (NTPs). Increasingly, countries are developing more robust national surveillance systems; implementing multiple health surveys; and using data analysis and visualization tools in policy, planning, programming and investment decisions. However, as more data are generated and data analysis tools evolve and increase in number, it can be challenging to understand how, why and when these tools should be implemented. The document summarizes information about the key tools related to data and evidence that are available for use in tuberculosis (TB) planning and programming, and how they can be applied. The tools that are profiled are described in terms of how they fit within the People-centred framework for TB programme planning and prioritization. It can also be used independently to inform decisions taken by NTPs about the implementation of the tools included in this document. Together with the people-centred framework, this compendium aims to enable better use of data and evidence for TB programme planning at both the national and subnational levels. It is designed to help NTPs and their national stakeholders to understand how and when different data and evidence-related tools could be used.